Menlo Park, CA, United States of America

Andrei Afanasiev


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Andrei Afanasiev in Biological Metrics Measurement

Introduction

Andrei Afanasiev is an accomplished inventor based in Menlo Park, California. He has made significant contributions to the field of biomedical engineering, particularly in the measurement of biological metrics and blood vessel geometry. His innovative work has the potential to enhance medical diagnostics and patient monitoring.

Latest Patents

Afanasiev holds a patent for "Systems and methods for measuring biological metrics and blood vessel geometry using a multiple optical path photoplethysmography device." This invention includes systems and methods for monitoring blood flow metrics using a flexible substrate patch that attaches to the skin over a blood vessel. The patch is equipped with multiple light sources arranged in a matrix and a row of photodetectors aligned with the light sources. The optical signal interface drives each light source and inputs intensity signals at the photodetectors. These signals are analyzed to determine AC and DC components for each optical path, allowing for the calculation of ratio-of-ratio values that can be used to assess biological metrics or the cross-sectional area of blood vessels.

Career Highlights

Afanasiev is currently employed at Alio, Inc., where he continues to develop innovative solutions in the biomedical field. His work is characterized by a strong focus on practical applications that can improve healthcare outcomes.

Collaborations

He collaborates with notable colleagues, including Forrest Miller and Francis Honore, who contribute to the advancement of their shared projects and innovations.

Conclusion

Andrei Afanasiev's contributions to the field of biomedical engineering through his innovative patent demonstrate his commitment to improving healthcare technology. His work has the potential to significantly impact how biological metrics are measured and monitored in clinical settings.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…